This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...